Cited by 211

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Erionite exposure in North Dakota and Turkish villages with mesothelioma

Carbone, Michele, Baris, Y. Izzettin, Bertino, Pietro, Brass, Brian, Comertpay, Sabahattin, Dogan, A. Umran, Gaudino, Giovanni, Jube, Sandro, Kanodia, Shreya, Partridge, Charles R., Pass, Harvey I., Rivera, Zeyana S., Steele, Ian, Tuncer, Murat, Way, Steven, Yang, Haining, Miller, Aubrey·2011·Proceedings of the National Academy of Sciences

Abstract

Exposure to erionite, an asbestos-like mineral, causes unprecedented rates of malignant mesothelioma (MM) mortality in some Turkish villages. Erionite deposits are present in at least 12 US states. We investigated whether increased urban development has led to erionite exposure in the United States and after preliminary exploration, focused our studies on Dunn County, North Dakota (ND). In Dunn County, ND, we discovered that over the past three decades, more than 300 miles of roads were surfaced with erionite-containing gravel. To determine potential health implications, we compared erionite from the Turkish villages to that from ND. Our study evaluated airborne point exposure concentrations, examined the physical and chemical properties of erionite, and examined the hallmarks of mesothelial cell transformation in vitro and in vivo. Airborne erionite concentrations measured in ND along roadsides, indoors, and inside vehicles, including school buses, equaled or exceeded concentrations in Boyali, where 6.25% of all deaths are caused by MM. With the exception of outdoor samples along roadsides, ND concentrations were lower than those measured in Turkish villages with MM mortality ranging from 20 to 50%. The physical and chemical properties of erionite from Turkey and ND are very similar and they showed identical biological activities. Considering the known 30- to 60-y latency for MM development, there is reason for concern for increased risk in ND in the future. Our findings indicate that implementation of novel preventive and early detection programs in ND and other erionite-rich areas of the United States, similar to efforts currently being undertaken in Turkey, is warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1105887108

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 35

  1. 10.1136/thx.33.2.181 · DOI
  2. M Artvinli, YI Bariş, Malignant mesotheliomas in a small village in the Anatolian region of Turkey: An epidemiologic study. J Natl Cancer Inst 63, 17–22 (1979).
  3. 10.1093/jnci/djj106 · DOI
  4. P Sebastien, A Gaudichet, J Bignon, YI Baris, Zeolite bodies in human lungs from Turkey. Lab Invest 44, 420–425 (1981).
  5. 10.1038/bjc.1985.108 · DOI
  6. 10.3109/08958379209145671 · DOI
  7. RJ Hill, RE Edwards, P Carthew, Early changes in the pleural mesothelium following intrapleural inoculation of the mineral fibre erionite and the subsequent development of mesotheliomas. J Exp Pathol (Oxford) 71, 105–118 (1990).
  8. International Agency for Research in Cancer Monographs on the Evaluation of Carcinogeneic Risks to Humans (World Health Organization, Geneva) 42, 225–239 (1987).
  9. YI Baris, Fibrous zeolite (erionite)-related diseases in Turkey. Am J Ind Med 19, 374–378 (1991).
  10. 10.2214/ajr.161.3.8394641 · DOI
  11. 10.1002/ijc.22687 · DOI
  12. 10.1177/1420326X08099908 · DOI
  13. CR Kliment, K Clemens, TD Oury, North American erionite-associated mesothelioma with pleural plaques and pulmonary fibrosis: A case report. Int J Clin Exp Pathol 2, 407–410 (2009).
  14. 10.1038/nrc2068 · DOI
  15. RA Sheppard, Zeolites in sedimentary deposits of the United States? A Review. Molecular Sieve Zeolites-I, Advances in Chemistry (American Chemical Society, Washington, DC) Vol 101, 279–310 (1974). · DOI
  16. N Forsman, Erionite in tuffs of North Dakota: The need for erionite hazard maps. Geological Society of America (Boulder, CO) Abstracts with Programs 38:7, 366 (2006).
  17. 10.1177/1420326X03039065 · DOI
  18. 10.1007/s10653-008-9165-x · DOI
  19. 10.1080/10937404.2011.556046 · DOI · Paper page
  20. 10.2138/am-1998-5-618 · DOI
  21. 10.1073/pnas.1006542107 · DOI · Paper page
  22. 10.1073/pnas.0604008103 · DOI · Paper page
  23. 10.1289/ehp.1002862 · DOI · Paper page
  24. BS Goodman, Erionite, a naturally occurring fibrous mineral hazard in the tri-state area of North Dakota, South Dakota, and Montana. Geological Society of America Abstracts with Programs 42, 5 (2010).
  25. 10.1073/pnas.170207097 · DOI
  26. 10.1158/0008-5472.CAN-04-0255 · DOI
  27. M Carbone, et al., Malignant mesothelioma: Facts, myths and hypotheses. J Cell Physiol, 10.1002/jcp.22724, 2011). · DOI
  28. 10.1111/j.1749-6632.1979.tb18741.x · DOI
  29. 10.2105/AJPH.75.6.615 · DOI
  30. 10.1289/ehp.0901680 · DOI
  31. 10.1289/ehp.6346 · DOI · Paper page
  32. 10.1038/468884a · DOI
  33. 10.1038/nrc774 · DOI · Paper page
  34. 10.1016/j.jtcvs.2007.10.054 · DOI
  35. S Tsuchiya, et al., Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 42, 1530–1536 (1982).

Cited by

Sorted by citations

Metadata

Authors
Carbone, M., Baris, Y. I., Bertino, P., Brass, B., Comertpay, S., Dogan, A. U., Gaudino, G., Jube, S., Kanodia, S., Partridge, C. R., Pass, H. I., Rivera, Z. S., Steele, I., Tuncer, M., Way, S., Yang, H., & Miller, A.
Affiliations
  • University of Hawaii Cancer Center, University of Hawaii, Honolulu, HI 96813;
  • Hacettepe University, Ankara, Turkey 06500;
  • United States Environmental Protection Agency, Denver, CO 80202;
  • Department of Earth Sciences, King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia 31261;
  • NYU Langone Medical Center and Cancer Center, New York University, New York, NY 10016;
  • Department of the Geophysical Sciences, University of Chicago, Chicago, IL 60637;
  • National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD 27709
Venue
Proceedings of the National Academy of Sciences
Published
2011-07-25
Volume
108
Issue
33
Pages
13618-13623
ISSN
  • 0027-8424
  • 1091-6490
Cited by
211
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review